Recombinant human epoetin beta in the treatment of chemotherapy-related anemia

Anemia is a common complication of systemic anti-cancer treatment. In this context epoetin beta, like other erythropoiesis-stimulating agents (ESAs), has demonstrable efficacy in raising Hb concentration and reducing the requirement for red cell transfusion. Consequently ESA therapy has gained incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Macpherson, Iain RJ, Lindsay, Colin R, Reed, Nicholas S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697520/
https://www.ncbi.nlm.nih.gov/pubmed/19436615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697520/
https://www.ncbi.nlm.nih.gov/pubmed/19436615

Ejemplares similares